Radiation-induced xerostomia

被引:59
作者
Chambers, Mark S.
Rosenthal, David I.
Weber, Randal S.
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2007年 / 29卷 / 01期
关键词
xerostomia; radiation therapy; radioprotective agents; intensity modulated radiation therapy; oral complications;
D O I
10.1002/hed.20456
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. Radiation-induced xerostomia is a frequent and usually permanent side effect of radiation therapy for head and neck cancer. We summarize recent developments in the prevention and treatment of radiation-induced xerostomia. Methods. The Medline database was searched for articles published within the past 10 years on the prevention and treatment of postirradiation xerostomia. Proceedings of recent important national meetings and government Web registries of clinical trials and therapeutic agents were also consulted. Priority was given to randomized controlled trials but, because of the scarcity of such trials, small open trials were included in this review. No other predetermined selection criteria were used, although articles exploring the effects of xerostomia and its treatment on quality of life were considered of special interest. Results. A variety of preventive approaches for postirradiation xerostomia exist, involving more conformal radiation delivery technology, radioprotective agents, and even preirradiation surgical techniques. Therapeutic interventions include supportive care, saliva supplementation, and the use of procholinergic salivary secretagogues. Conclusions. Radiation-induced xerostomia constitutes a significant morbidity after orofacal irradiation. Careful preventive techniques, meticulous supportive care, and new preventive and therapeutic agents may prove useful in combination. (c) 2006 Wiley Periodicals, Inc.
引用
收藏
页码:58 / 63
页数:6
相关论文
共 36 条
  • [1] Atkinson J C, 2001, J Dent Educ, V65, P1096
  • [2] Salivary gland protection by amifostine in high-dose radioiodine treatment: Results of a double-blind placebo-controlled study
    Bohuslavizki, KH
    Klutmann, S
    Brenner, W
    Mester, J
    Henze, E
    Clausen, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (11) : 3542 - 3549
  • [3] Brizel DM, 2004, J CLIN ONCOL, V22, p497S
  • [4] Bruce Susan D, 2004, Clin J Oncol Nurs, V8, P61, DOI 10.1188/04.CJON.61-67
  • [5] *CANC THER EV PROG, 2003, COMM TERM CRIT ADV E
  • [6] Radiation-induced xerostomia in patients with head and neck cancer: Pathogenesis, impact on quality of life, and management
    Chambers, MS
    Garden, AS
    Kies, MS
    Martin, JW
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2004, 26 (09): : 796 - 807
  • [7] CHAMBERS MS, 2005 ANN M AM SOC CL
  • [8] Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparisons with conventional techniques
    Chao, KSC
    Majhail, N
    Huang, CJ
    Simpson, JR
    Perez, CA
    Haughey, B
    Spector, G
    [J]. RADIOTHERAPY AND ONCOLOGY, 2001, 61 (03) : 275 - 280
  • [9] *DAIICH PHARM CORP, 2005, EV CAPS CEV HYDR PAC
  • [10] Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer
    Eisbruch, A
    Kim, HM
    Terrell, JE
    Marsh, LH
    Dawson, LA
    Ship, JA
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (03): : 695 - 704